Balanced Transfusion Reduces Trauma Mortality After Six Red Cell Units

The Critical Thresholds of Hemorrhagic Shock Resuscitation

Managing traumatic hemorrhage requires a rapid transition from initial stabilization to aggressive volume replacement to prevent the lethal triad of acidosis, hypothermia, and coagulopathy. Current clinical practice guidelines emphasize the early identification of trauma-induced coagulopathy (a systemic impairment of the clotting cascade following severe injury), a distinct clinical entity that necessitates immediate therapeutic intervention [1]. While the use of balanced blood component therapy is well-established in adult populations, the optimal strategy for maintaining this balance, including the role of whole blood versus component therapy, remains a subject of active investigation [2, 3]. Clinicians must also weigh these resuscitation strategies against other critical interventions, such as permissive hypotension (the deliberate maintenance of subnormal blood pressure to limit further hemorrhage) and the timely administration of antifibrinolytics [4, 5]. A multi-study analysis of 4,858 patients now demonstrates that balanced resuscitation ratios of 1:1 or less (red blood cells to plasma) significantly reduce mortality once transfusion volumes exceed 6 to 10 units of red blood cells [6]. For practicing trauma teams, understanding these specific volume thresholds is essential for refining massive transfusion protocols and timing the delivery of plasma and whole blood in the acute phase of care.

Comparative Analysis Across Four Major Trauma Cohorts

To identify the precise inflection points where transfusion ratios alter clinical outcomes, researchers conducted a comprehensive analysis of 4,858 traumatic hemorrhage patients across four distinct study populations. This large-scale evaluation bridged two eras of trauma care, comparing outcomes from the period before whole blood was widely available to more recent data incorporating its use. The pre-whole blood era was represented by a single-institution experience involving 1,266 patients (Pre-WB Single Center, 2010 to 2016) and the multicenter Pre-WB Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial, which included 680 patients from 2012 to 2013. These cohorts provided a baseline for component-based therapy before the integration of cold-stored whole blood into standard massive transfusion protocols. The modern era of resuscitation was captured through two additional studies conducted during the period of whole blood availability. These included a single-institution experience with 2,118 patients (WB Single Center, 2017 to 2021) and the prospective, multicenter WB Shock, Whole blood And Traumatic brain injury (SWAT) study, which enrolled 1,034 patients between 2018 and 2021. Across all four populations, researchers divided patients into two cohorts based on the ratio of red blood cells to plasma administered. The balanced cohort was defined by a ratio of 1:1 or less, while the unbalanced cohort received a ratio greater than 1:1. To track the impact of these ratios as hemorrhage progressed, the researchers evaluated red blood cell units transfused within the first four hours of arrival, using specific volume intervals of 0 to 6 units, 7 to 10 units, and subsequent 10-unit increments. The primary endpoint for the analysis was 30-day mortality, with secondary outcomes focused on acute survival at the four-hour and 24-hour marks. The statistical power of the study was derived from the substantial size of the individual cohorts. In the Pre-WB Single Center study, the balanced and unbalanced groups consisted of 730 and 536 patients, respectively. The Pre-WB PROPPR trial included 342 balanced and 338 unbalanced patients. In the more recent whole blood era, the WB Single Center study compared 1,239 balanced patients against 879 unbalanced patients, while the WB SWAT study included 447 patients in the balanced cohort and 587 in the unbalanced cohort. By stratifying these patients by both transfusion ratio and volume, the authors sought to pinpoint exactly when a 1:1 resuscitation strategy begins to confer a survival advantage, providing clinicians with actionable targets during active hemorrhage.

Volume-Dependent Survival Benefits in Component Therapy

In the era before whole blood was readily available, the survival benefit of maintaining a 1:1 ratio of plasma to red blood cells became most apparent as transfusion volumes increased. Data from the Pre-WB Single Center study and the Pre-WB PROPPR trial demonstrated that mortality differences emerged once patients required more than 10 units of red blood cells. This threshold often corresponds to the transition to a second transfusion cooler in many trauma centers, marking a critical juncture where the cumulative deficit of coagulation factors in unbalanced resuscitation begins to manifest clinically. For patients receiving between 11 and 20 units of red blood cells, the Pre-WB Single Center study showed a mortality rate of 26 percent in the balanced cohort compared to 32 percent in the unbalanced cohort (P = 0.151). Similarly, the Pre-WB PROPPR trial reported mortality rates of 20 percent for balanced resuscitation versus 30 percent for unbalanced resuscitation within the same 11 to 20 unit volume range (P = 0.090). As the severity of hemorrhage necessitated even higher volumes, the protective effect of balanced component therapy became statistically significant and clinically pronounced. For patients requiring 21 to 30 units of red blood cells, the survival gap widened substantially. In the Pre-WB Single Center cohort, mortality was 43 percent for those receiving balanced ratios compared to 71 percent for the unbalanced group (P = 0.013). The Pre-WB PROPPR trial mirrored this trend, reporting a mortality rate of 32 percent in the balanced cohort versus 61 percent in the unbalanced cohort (P = 0.017). These findings suggest that while the benefits of a 1:1 ratio may be subtle during the initial stages of resuscitation, the prevention of dilutional coagulopathy (a condition where clotting factors are depleted by the administration of red cells and crystalloid fluids without adequate plasma replacement) becomes a primary determinant of survival as the total transfusion volume exceeds 20 units.

The Impact of Whole Blood on Resuscitation Thresholds

The integration of whole blood into trauma resuscitation protocols shifted the clinical threshold at which balanced ratios impact survival. In the two cohorts utilizing whole blood, the WB Single Center study (n = 1,239 balanced, n = 879 unbalanced) and the prospective, multicenter WB SWAT study (n = 447 balanced, n = 587 unbalanced), researchers noted an outcome separation at more than 6 units of red blood cells. This earlier divergence suggests that the use of whole blood may influence the physiological response to hemorrhage sooner than component therapy alone, requiring clinicians to be vigilant about balanced ratios even earlier in the resuscitation process. For patients receiving between 7 and 10 units, the WB Single Center study reported a mortality rate of 14 percent in the balanced cohort compared to 22 percent in the unbalanced cohort (P = 0.139). Similarly, the WB SWAT study showed mortality rates of 14 percent for balanced resuscitation versus 18 percent for unbalanced resuscitation in the same 7 to 10 unit range (P = 0.198). As transfusion requirements increased to the 11 to 20 unit interval, the survival advantage of maintaining a 1:1 ratio became more pronounced. In the WB Single Center study, mortality for patients in this range was 28 percent for the balanced group and 41 percent for the unbalanced group (P = 0.118). The WB SWAT study demonstrated a statistically significant benefit at this volume, with mortality rates of 17 percent in the balanced cohort versus 31 percent in the unbalanced cohort (P = 0.030). Across all analyzed cohorts, the researchers observed that absolute mortality differences tended to widen as the total number of units transfused increased, reinforcing the critical importance of sustained balanced resuscitation during massive hemorrhage. These data indicate that while the most dramatic survival benefits are seen at higher volumes, the protective effect of a 1:1 ratio begins to manifest significantly earlier in the modern era of whole blood utilization.

Clinical Implications for Massive Hemorrhage Protocols

The survival benefits associated with balanced resuscitation extend beyond immediate stabilization, manifesting clearly in short-term outcomes. Analysis of the data shows that mortality differences remained significant at 24 hours for the 7 to 10 unit range in the Pre-WB Single Center study, which included 730 patients in the balanced cohort and 536 in the unbalanced cohort. This early divergence in survival underscores the importance of achieving a 1:1 ratio of red blood cells to plasma even before massive transfusion volumes are reached. Furthermore, mortality differences remained significant at 24 hours for the 11 to 20 unit range in the Pre-WB PROPPR trial, the WB Single Center study, and the WB SWAT study. These findings across three distinct cohorts, involving both component therapy and whole blood, suggest that the physiological benefits of plasma-heavy resuscitation are sustained throughout the first critical day of trauma care. Based on this analysis of nearly 5,000 patients, the researchers concluded that balanced resuscitation is protective during or after the administration of the second transfusion cooler, which typically corresponds to more than 6 or 10 units of red blood cells. This inflection point serves as a critical clinical marker for trauma teams. To optimize survival, clinicians should initiate 1:1 resuscitation immediately upon the suspicion of massive hemorrhage. The data support the strategic use of early whole blood to maintain this balance from the outset of treatment. For centers relying on component therapy, these results highlight the necessity of storing more immediately available plasma to ensure that the 1:1 ratio is not compromised during the rapid administration of the first and second transfusion coolers.

References

1. Lier H, Gooßen K, Kugler CM, et al. Inhospital coagulation management and fluid replacement therapy in patients with multiple and/or severe injuries – a systematic review and clinical practice guideline update. European Journal of Trauma and Emergency Surgery. 2025. doi:10.1007/s00068-025-02919-2

2. Crowe E, DeSantis SM, Bonnette A, et al. Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta‐analysis. Journal of the American College of Emergency Physicians Open. 2020. doi:10.1002/emp2.12089

3. Smith J, Barnard E, Brown-O’Sullivan C, et al. The SWiFT trial (Study of Whole Blood in Frontline Trauma)—the clinical and cost effectiveness of pre-hospital whole blood versus standard care in patients with life-threatening traumatic haemorrhage: study protocol for a multi-centre randomised controlled trial. Trials. 2023. doi:10.1186/s13063-023-07711-4

4. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. The Lancet. 2019. doi:10.1016/s0140-6736(19)32233-0

5. Albreiki M, Voegeli D. Permissive hypotensive resuscitation in adult patients with traumatic haemorrhagic shock: a systematic review. European Journal of Trauma and Emergency Surgery. 2017. doi:10.1007/s00068-017-0862-y

6. Clements TW, Williams J, Cannon JW, et al. When does 1:1 resuscitation really matter? An analysis of 4,858 patients from four traumatic hemorrhage studies. Journal of Trauma and Acute Care Surgery. 2026. doi:10.1097/ta.0000000000005037